Periodontitis
2
Pipeline Programs
3
Companies
5
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Geistlich PharmaSwitzerland - Root
3 programs1
1
PerioSeptPhase 21 trial
PerioSeptPhase 1/21 trial
Access flap & surgical debridementN/A1 trial
Active Trials
Ondine BiomedicalBC - Vancouver
1 programlight activated dye photodynamic therapyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Geistlich PharmaPerioSept
Geistlich PharmaPerioSept
Geistlich PharmaAccess flap & surgical debridement
Bausch HealthSRP + MM
Ondine Biomedicallight activated dye photodynamic therapy
Clinical Trials (5)
Total enrollment: 339 patients across 5 trials
Trial to Evaluate Safety, Tolerability, Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis
Start: Aug 2019Est. completion: Sep 202012 patients
Phase 2Completed
A Phase I/II Study to Evaluate the Safety and Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis
Start: Jul 2015Est. completion: Jul 2018127 patients
Phase 1/2Completed
Use of a Bone Substitute Material in the Surgical Therapy of Furcation Defects
Start: Mar 2025Est. completion: Mar 2037200 patients
N/ARecruiting
Influence of SRP With MM on the Composition and Functional Characteristics of Subgingival Microbiome Communities
Start: Oct 2021Est. completion: Dec 2025
N/AActive Not Recruiting
Photodynamic Therapy Plus Root Debridement in Gum Disease Treatment V2
Start: Oct 2017Est. completion: Sep 2018
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 339 patients
3 companies competing in this space